# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Demyelinating Diseases

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 81-90 of 549 results.
A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Status: Recruiting
Last Changed: Oct 05, 2020
First Received: Mar 04, 2019
Disease(s): Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Intervention(s): Rozanolixizumab, Placebo
Locations: Cidp01 902, Phoenix, Arizona, United States
Cidp01 905, Los Angeles, California, United States
Cidp01 901, Tampa, Florida, United States
Cidp01 907, Augusta, Georgia, United States
Cidp01 904, Fairway, Kansas, United States
... and 24 other locations.
Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing
Status: Not yet recruiting
Last Changed: May 05, 2020
First Received: Apr 22, 2020
Disease(s): Multifocal Motor Neuropathy (MMN), Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Processing Integration in Neurological Patients Using fMRI
Status: Not yet recruiting
Last Changed: Mar 29, 2016
First Received: Mar 29, 2016
Disease(s): Acute Inflammatory Demyelinating Polyradiculoneuropathy, Stroke, Anosognosia, Central and Peripheral Neurodegenerative Pathologies, Neuropsychiatric Conditions
Intervention(s): 3 Tesla Siemens Skyra MRI scanner
Discontinuing Disease-modifying Therapies in Stable Relapsing - Onset Multiple Sclerosis (DOT-MS).
Status: Recruiting
Last Changed: Oct 19, 2020
First Received: Feb 07, 2020
Disease(s): Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive
Intervention(s): DMT
Locations: Amsterdam UMC, Amsterdam, Netherlands
Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients.
Status: Recruiting
Last Changed: Aug 07, 2020
First Received: Aug 09, 2018
Disease(s): Multiple Sclerosis, Relapsing MS, Advancing Multiple Sclerosis
Intervention(s): Siponimod
Locations: Novartis Investigative Site, Birmingham, Alabama, United States
Novartis Investigative Site, Cullman, Alabama, United States
Novartis Investigative Site, Tucson, Arizona, United States
Novartis Investigative Site, Berkeley, California, United States
Novartis Investigative Site, Carmichael, California, United States
... and 67 other locations.
Biomarkers in Polyradiculoneuropathies
Status: Recruiting
Last Changed: Jan 31, 2020
First Received: Jan 31, 2020
Disease(s): Guillain-Barre Syndrome, CIDP
Locations: UH Montpellier, Montpellier, France
Effect of Ankle-foot Orthoses on Balance Confidence
Status: Recruiting
Last Changed: Feb 07, 2020
First Received: Sep 06, 2019
Disease(s): Peripheral Nerve Disease, Peripheral Nerve Injury Lower Limb, Poliomyelitis, Cerebral Palsy, Multiple Sclerosis
Intervention(s): Ankle-foot orthosis
Locations: University Rehabilitation Institute, Republic of Slovenia, Ljubljana, Slovenia
Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP
Status: Recruiting
Last Changed: Nov 25, 2019
First Received: Nov 04, 2016
Disease(s): Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Intervention(s): HYQVIA
Locations: Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
Fakultni nemocnice Ostrava, Ostrava, Poruba, Czechia
Fakultni nemocnice v Motole, Dept of Neurologicka klinika 2. LF UK a FN Motol, Prague 5, Czechia
Århus Universitetshospital, Neurologisk, Aarhus C, Denmark
Groupe Hospitalier Pellegrin - Hôpital Pellegrin, Bordeaux Cedex, Gironde, France
... and 16 other locations.
Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) Before and During Treatment With Ocrelizumab
Status: Recruiting
Last Changed: Oct 19, 2020
First Received: May 06, 2020
Disease(s): Multiple Sclerosis, Relapsing
Intervention(s): Ocrelizumab
Locations: HonorHealth Neurology, Scottsdale, Arizona, United States
USC Keck School Of Medicine, Los Angeles, California, United States
Georgetown University Medical Center, Washington, District of Columbia, United States
Baptist Neurology - Beaches, Jacksonville Beach, Florida, United States
University of Miami Miller School of Medicine, Miami, Florida, United States
... and 28 other locations.
Clinical and Imaging Patterns of Neuroinflammation Diseases in China (CLUE)
Status: Recruiting
Last Changed: Oct 08, 2019
First Received: Sep 27, 2019
Disease(s): NMO Spectrum Disorder, MRI, Multiple Sclerosis
Intervention(s): Intravenous steroid
Locations: Beijing Tiantan Hospital, Beijing, Beijing, China